Electroporation-mediated delivery of 3'-protected phosphodiester oligodeoxynucleotides to the skin.
The feasibility of topical delivery in the skin of 3' end modified phosphodiester oligonucleotides using electroporation was investigated. Experiments were performed in vitro, using hairless rat skin. Five pulses of (200 V, 450 ms) were applied. The 3' end modifications of the 15 mer oligonucleotide were: (1) 3'-aminohexyl, (2) biotin, with a triethyleneglycol arm, (3) methylphosphonate links between nucleotides 13, 14 and 15, and (4) 2-O-methyl nucleotides at 13, 14 and 15 positions. All the modifications were efficient to protect the oligonucleotides against degradation in the skin. Electroporation increased the topical delivery of the 3' end-modified phosphodiesters by two orders of magnitude compared to passive diffusion, without significant differences between the derivatives. Oligonucleotide concentrations in the range of 1 microm could be achieved in the viable skin. The delivery of a phosphorothioate congener was lower than phosphodiester delivery due to the interaction of phosphorothioate with the stratum corneum. Consequently, 3' end-protected phosphodiesters could be an interesting alternative to phosphorothioate oligonucleotides for topical treatment of cutaneous diseases.
Regnier
V
V
Université Catholique de Louvain, Unité de Pharmacie Galénique, Avenue E. Mounier, 73 UCL 73.20, 1200, Brussels, Belgium.
Tahiri
A
A
André
N
N
Lemaître
M
M
Le Doan
T
T
Préat
V
V
D000287:Administration, Topical; D000818:Animals; D018274:Electroporation / Q000379:methods*; D066298:In Vitro Techniques; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D051381:Rats; D012869:Skin Absorption / Q000502:physiology*
D009838:Oligodeoxyribonucleotides